The Journal of
Clinical Psychiatry

Volume 60 • 1999 • Supplement 10

Article

Article

Introduction. What Makes an Antipsychotic Atypical?

J Clin Psychiatry 1999;60(suppl 10):3-4

Stephen M. Stahl, MD, PhD

Article

Receptor Pharmacology of Neuroleptics: Relation to Clinical Effects

J Clin Psychiatry 1999;60(suppl 10):5-14

Elliott Richelson, MD

Article

D2 and 5-HT2 Receptor Effects of Antipsychotics: Bridging Basic and Clinical Findings Using PET

J Clin Psychiatry 1999;60(suppl 10):15-19

Shitij Kapur, MD, PhD, FRCPC; Gary Remington, MD, PhD, FRCPC

Article

Pharmacologic and Pharmacokinetic Considerations in Choosing an Antipsychotic

J Clin Psychiatry 1999;60(suppl 10):20-30

Larry Ereshefsky, PharmD, FCCP, BCCP

Article

Selecting an Atypical Antipsychotic by Combining Clinical Experience With Guidelines From Clinical Trials

J Clin Psychiatry 1999;60(suppl 10):31-41

Stephen M. Stahl, MD, PhD

Article

Does Loxapine Have "Atypical" Properties? Clinical Evidence

J Clin Psychiatry 1999;60(suppl 10):42-46

William M. Glazer, MD

Article

Low-Dose Loxapine in the Treatment of Schizophrenia: Is It More Effective and More "Atypical" Than Standard-Dose Loxapine?

J Clin Psychiatry 1999;60(suppl 10):47-51

Herbert Y. Meltzer, MD; Karuna Jayathilake, MA

Article

The Role of Typical and Atypical Antipsychotic Medications in the Management of Agitation and Aggression

J Clin Psychiatry 1999;60(suppl 10):52-60

Peter F. Buckley, MD